Posted by Michael Wonder on 14 Jan 2026
TGA approves registration of lenacapavir for pre-exposure prophylaxis for HIV (Yeytuo)
9 January 2026 - On 17 December 2025, the TGA made the decision to approve the registration of lenacapavir (Yeytuo).
Yeytuo is indicated for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 in adults and adolescents 16 years and older weighing at least 35 kg.
